396 related articles for article (PubMed ID: 31035440)
1. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.
Mukherjee A; Paul M; Mukherjee S
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035440
[TBL] [Abstract][Full Text] [Related]
2. Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics.
Madamsetty VS; Paul MK; Mukherjee A; Mukherjee S
ACS Biomater Sci Eng; 2020 Jan; 6(1):167-181. PubMed ID: 33463233
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine-based adjuvant therapy: a promising solution for lung cancer.
Xu Y; Hsu JC; Xu L; Chen W; Cai W; Wang K
J Nanobiotechnology; 2023 Jul; 21(1):211. PubMed ID: 37415158
[TBL] [Abstract][Full Text] [Related]
8. Recent progress of nanotechnology-based theranostic systems in cancer treatments.
Xue Y; Gao Y; Meng F; Luo L
Cancer Biol Med; 2021 Apr; 18(2):336-51. PubMed ID: 33861527
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
10. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
11. Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect.
Karati D; Mukherjee S; Dutta A; Ash D; Ganguly SC; Acharya A; Basu B
Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38756071
[TBL] [Abstract][Full Text] [Related]
12. Novel nanoparticulate systems for lung cancer therapy: an updated review.
Madni A; Batool A; Noreen S; Maqbool I; Rehman F; Kashif PM; Tahir N; Raza A
J Drug Target; 2017 Jul; 25(6):499-512. PubMed ID: 28151021
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress in Nanomedicine for Melanoma Theranostics With Emphasis on Combination Therapy.
Guan M; Zhu S; Li S
Front Bioeng Biotechnol; 2021; 9():661214. PubMed ID: 33777924
[TBL] [Abstract][Full Text] [Related]
14. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials.
Agnihotri TG; Gomte SS; Jain A
Drug Dev Ind Pharm; 2022 Nov; 48(11):585-601. PubMed ID: 36448770
[TBL] [Abstract][Full Text] [Related]
15. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
16. New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment.
Mottaghitalab F; Farokhi M; Fatahi Y; Atyabi F; Dinarvand R
J Control Release; 2019 Feb; 295():250-267. PubMed ID: 30639691
[TBL] [Abstract][Full Text] [Related]
17. Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics.
Madamsetty VS; Mukherjee A; Mukherjee S
Front Pharmacol; 2019; 10():1264. PubMed ID: 31708785
[TBL] [Abstract][Full Text] [Related]
18. Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
de Sousa Cunha F; Dos Santos Pereira LN; de Costa E Silva TP; de Sousa Luz RA; Nogueira Mendes A
J Drug Target; 2019 Aug; 27(7):732-741. PubMed ID: 30207742
[TBL] [Abstract][Full Text] [Related]
19. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
20. PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application.
Grossen P; Witzigmann D; Sieber S; Huwyler J
J Control Release; 2017 Aug; 260():46-60. PubMed ID: 28536049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
